Germany - Baker & McKenzie advised Montagu Private Equity ("Montagu") comprehensively on the sale of their stake in Euro Medic International ("Euro Medic") to Ares Life Sciences ("Ares"). Ares is a Waypoint Capital owned investment partnership and previous majority shareholder of Euro Medic. The transaction is expected to be completed in 2014, subject to relevant regulatory approvals.

Established in 1991, Euro Medic is the largest pan-European provider of medical services specializing in premium diagnostic imaging, cancer detection and cancer treatment services. The company currently operates 144 diagnostic and cancer treatment centers in 14 European countries. Euro Medic employs over 3,000 professionals, of which more than 750 are medical doctors.

Under the lead of Dr. Joachim Drude, corporate partner in Dusseldorf, Baker & McKenzie advised Montagu in relation to the Euro Medic Group on several occasions in the past. Most recently, Baker & McKenzie advised Montagu on the increase of its interest in Euro Medic as part of the buy-out by Bank of America Merrill Lynch.

Legal Adviser Montagu:

Baker & McKenzie

Lead: Corporate: Dr. Joachim Drude (partner, Dusseldorf).

Team: Corporate: Dr. Ingo Strauss (partner, Dusseldorf), David Allen (partner, London), Lena von Richthofen (associate, Dusseldorf), Torsten Schmitt (senior associate, Luxembourg), William Tanguy (associate, Luxembourg), James Adams (associate, London).

Antitrust: Christian Horstkotte (partner, Dusseldorf).